Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

A patient with TB shows the pills for his treatment in a prison in Donetsk, Ukraine, where MSF is helping to treat patients infected with TB. MSF has been running a TB treatment program within the penitentiary system in Donetsk since 2011. Photograph by Manu Brabo
Press release
Press release |
20 March 2015
Tuberculosis

Leading medical organisations team up to bring new TB treatments to those in need

4 min
Press release |
18 March 2015
Hepatitis C

Indian generic companies should reject Gilead’s controversial hepatitis C ‘Anti-Diversion’ programme

5 min
MSF lab technician working in the lab at the Nhlangano TB ward in Shiselweni, Swaziland. Photograph by Giorgos Moutafis Photograph by Giorgos Moutafis
Press release
Press release |
16 March 2015
Tuberculosis
MozambiqueSouth AfricaEswatini

Multi-drug resistant TB strain in Swaziland not detectable by most advanced rapid diagnostic tests

Metro advertisements for Doctors Without Borders, photos by Drew Angerer Photograph by Drew Angerer
Press release
Press release |
11 March 2015
Intellectual property and trade

MSF statement on the latest round of TPP trade talks in Hawaii this week

3 min
Discussion between team members, amongst which Clinical health officer Kenie Musa, before going in to the high-risk zone. Photograph by Anna Surinyach Photograph by Anna Surinyach
Press release
Press release |
25 February 2015
Tropical & neglected diseases
Liberia

Preliminary Results of the JIKI Clinical Trial to test the Efficacy of Favipiravir in Reducing Mortality in Individuals Infected by Ebola Virus in Guinea

The highest TB rates in Kyrgyzstan are in Kara-Suu district, Osh province. Weekly meeting of the local medical staff with the supervising and counselling staff of MSF. Case review before medical round. Photograph by Helmut Wachter
Press release
Press release |
17 February 2015
Tuberculosis
Armenia

Tuberculosis: a joint MSF / Ministries of Health symposium to discuss new treatments and approaches in Eastern Europe and Central Asia

4 min
Press release |
26 January 2015
Vaccines

At Berlin Vaccine Summit, World leaders try their luck at spinning ‘Pharma’s Wheel of Fortune’

2013 marked the first time that PCV is being used in South Sudan and one of the first vaccines to be implemented in compliance with the new WHO emergency vaccination recommendations. Photograph by Yann Libessart
Press release
Press release |
26 January 2015
Vaccines

MSF responds to Pfizer announcement of pneumococcal vaccine price reduction

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury